How to Get Retatrutide With a Clinical Trial Retatrutide phase 3 trials are winding up in 2026 with trial results that will lead to the anticipated FDA approval by summer 2026
Klinic specializes in telehealth-based weight management, which is why we prescribe the medications specifically approved for that indication: Wegovy, Oral Wegovy, Zepbound, and Foundayo
A separate report published in Nature Health, where the study appeared, emphasized that findings from social media should be treated as potential safety signals rather than confirmed medical evidence
While there is not currently any evidence suggesting a correlation between suicide and Ozempic use, the EMA investigation highlights the limited information on potential side effects associated with Wegovy and Ozempic
7,8 South Carolina Medicaid added coverage of weight loss GLP-1s on November 1, 2024, and recently removed coverage effective January 1, 2026
At the GLP-1R, it produces the same hypothalamic satiety signaling, gastric emptying delay, and beta-cell potentiation as selective GLP-1 agonists